PHIO icon

Phio Pharmaceuticals
PHIO

Overview Fund Activity

26 hedge funds and large institutions have $3.14M invested in Phio Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AFM
1
Anson Funds Management
Texas
$328K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$298K
3
Citadel Advisors
3
Citadel Advisors
Florida
$18K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$340K
5
BFA
5
BlackRock Fund Advisors
California
$5K

Top Sellers

1
BC
1
Broadfin Capital
New York
$1.96M
2
CS
2
Credit Suisse
Switzerland
$0
3
VKH
3
Virtu KCG Holdings
New York
$26K
4
AL
4
Airain Ltd
Guernsey
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MFS
26
MSI Financial Services
Massachusetts
$0 8 +8 New
TRCT
27
Tower Research Capital (TRC)
New York
$0 162 +162 New
Creative Planning
28
Creative Planning
Kansas
$0 409 +333 +438%
IA
29
IFP Advisors
Florida
$0 1,019 +1,019 New
Northwestern Mutual Wealth Management
30
Northwestern Mutual Wealth Management
Wisconsin
$0 1,042 +1,042 New
1
2